STAT+: Merck strikes voluntary licensing deals in poor countries for an experimental HIV prevention pill

Merck is striking licensing deals for its experimental HIV prevention pill in hope of getting wide-scale production started quickly.
Related Markets
All MarketsMarket data may be delayed. Not financial advice.
💡 AI analysis provides alternative perspectives on current events